Cancer imaging : the official publication of the International Cancer Imaging Society

Cancer Imaging · ISSN (e) 1470-7330 · 25 papers in corpus
2026
doi:10.1186/s40644-026-01013-z ·PMID:41764582

BACKGROUND: Ultrasound-based deep learning (DL) models for the precise diagnosis of endometrial cancer are insufficient. Our aim is to develop and validate an automatic multi-modal ultrasound DL prediction model for the accurate identificat…

2025
doi:10.1186/s40644-025-00918-5 ·PMID:40739593

PurposeDifferentiating between benign and malignant ovarian masses remains a significant clinical challenge. Although the Ovarian-Adnexal Reporting and Data System Ultrasound Version 2022 (O-RADS US v2022) provides standardized terminology …

2024
doi:10.1186/s40644-024-00714-7 ·PMID:38831467

BackgroundAccurate clinical staging is crucial for selection of optimal oncological treatment strategies in non-small cell lung cancer (NSCLC). Although brain MRI, bone scintigraphy and whole-body PET/CT play important roles in detecting di…

2019
doi:10.1186/s40644-019-0244-2 ·PMID:31511074
2018
doi:10.1186/s40644-018-0180-6 ·PMID:30514387

Endometrial cancer is the most common gynaecologic malignancy in developed countries and its incidence is increasing. First-level treatment, if no contraindicated, is based on surgery. Pre-operative imaging is needed for evaluation of local…

2018
doi:10.1186/s40644-018-0156-6 ·PMID:29970170

BackgroundThe invasion depth of endometrial cancer is one of the most important prognosis factors. The aim of the current study was to investigate the diagnostic value of the apparent diffusion coefficient (ADC) of the peritumoral zone for …

other 2016
doi:10.1186/s40644-016-0061-9 ·PMID:26873307

BACKGROUND: Primary epithelial ovarian carcinoma is sub-classified into serous, mucinous, endometrioid and clear cell subtypes. Neoadjuvant chemotherapy has become an alternative treatment option past several years, as serous carcinoma, the…

2016
doi:10.1186/s40644-016-0069-1 ·PMID:27157039

Endometrial cancer is the most common malignancy of the female pelvis. New concepts in endometrial cancer treatment emphasize the value of MRI as a major predictor of lymph node metastasis and tumour recurrence. MRI findings aid in triaging…

2015
doi:10.1186/1470-7330-15-s1-p42
2013
doi:10.1102/1470-7330.2013.0054 ·PMID:24434038

Gynecologic cancers are a leading cause of morbidity and mortality for female patients, with an estimated 88,750 new cancer cases and 29,520 deaths in the United States in 2012. To offer the best treatment options to patients it is importan…

2013
doi:10.1102/1470-7330.2013.0003 ·PMID:23439060

Mucinous neoplasms of the appendix are a heterogeneous group of neoplasms ranging from simple mucoceles to complex pseudomyxoma peritonei. Considerable controversy exists on their pathologic classification and nomenclature. Clear understand…

2011
doi:10.1102/1470-7330.2011.0013 ·PMID:21684828

Preoperative diagnosis of malignant transformation of an ovarian mature cystic teratoma to squamous cell carcinoma is difficult due to nonspecific tumor markers and imaging findings. This is an interesting case presentation that has prior i…

2011
doi:10.1102/1470-7330.2011.0008 ·PMID:21555262

There has been explosive growth in the utilization of cross-sectional imaging studies in the evaluation of patients with known or suspected abdominal and pelvic pathology. These imaging studies have led to a veritable epidemic of incidental…

2011
doi:10.1102/1470-7330.2011.0017 ·PMID:21771710

The objective of this review article is to learn how to recognize anatomic variants and benign entities that mimic bladder cancer at computed tomography (CT) urography. Building on recent data that suggest that CT urography can be used to d…

2010
doi:10.1102/1470-7330.2010.9021 ·PMID:20880789

Recent advances in multi-detector computed tomography, magnetic resonance imaging, and ultrasound have led to the detection of incidental ovarian, uterine, vascular and pelvic nodal abnormalities in both the oncology and non-oncology patien…

2009
doi:10.1102/1470-7330.2009.0007 ·PMID:19602469

Hemangiopericytoma, a rare mesenchymal tumour, is believed to originate from the pericyte of Zimmermann. It may affect every organ in the body. Recurrences after treatment and metastasis are well known. However, presentation of hemangioperi…

2009
doi:10.1102/1470-7330.2009.9046 ·PMID:19965304

This article describes the aetiology, epidemiology and clinical significance of incidental non-solid pulmonary nodules. Non-solid nodules are more likely malignant. If malignant, they are mostly due to atypical adenomatous hyperplasia and b…

2008
doi:10.1102/1470-7330.2008.0001 ·PMID:18226987
2008
doi:10.1102/1470-7330.2008.0020 ·PMID:18603495

Tamoxifen is a selective estrogen receptor modulator (SERM) that is widely used in the treatment of patients with breast cancer and for chemoprophylaxis in high risk women. Tamoxifen results in a spectrum of abnormalities involving the geni…

2007
doi:10.1102/1470-7330.2007.9046 ·PMID:17921097

Magnetic resonance (MR) imaging is increasingly being used in patients with gynaecological disorders due to its high contrast resolution compared to computed tomography (CT) and ultrasound. In women presenting with an adnexal mass, ultrasou…

2007
doi:10.1102/1470-7330.2007.9015 ·PMID:17921092

Gynecologic cancers are a common cause of morbidity and mortality in women of all ages. While many gynecologic cancers are staged clinically using the International Federation of Gynecology and Obstetrics (FIGO) staging system, imaging can …

2006
doi:10.1102/1470-7330.2006.0005 ·PMID:16581520

Tumoral dissemination of ovarian cancer most commonly occurs through the intra-peritoneal route; nevertheless, although it is rare, ovarian cancer may also metastasise through the lymphatic channels. Lymphatic diffusion of ovarian cancer us…

2006
doi:10.1102/1470-7330.2006.0016 ·PMID:16829471

Parameters that significantly influence results in radiation treatment of gynaecological malignancies are mainly related to the tumour characteristics and the radiotherapy technique used. High-dose radiotherapy requires accurate localisatio…

2006

The objectives of this presentation are to discuss the clinical role of magnetic resonance (MR) in local and nodal staging of prostate cancer, and to show new developments. The clinical questions are how can we improve with new MR imaging (…

2005